Algorics announces acquisition of Domain Clinical Data Sciences

June 7, 2021

Algorics, a provider of biostatistics and programming solutions for the pharmaceutical and biotechnology industry, today announced the acquisition of Domain Clinical Data Sciences "DCDS", a clinical data services organisation based in India.

The acquisition supports Algorics' commitment to expanding its team of experienced analytical professionals and sustaining its commercial growth.

Founded in 2013, Algorics specialises in biostatistics, programming, and data standardisation solutions for clinical trials. The company supports a global portfolio of biopharmaceutical and CRO clients with cost-effective and high-quality analytical services underpinned by technology know-how and access to high-quality talent in India. Domain Clinical Data Sciences also has a long track record of providing biostatistics and programming support.

The acquisition brings Algorics' headcount to 60 and expands the company's geographic footprint with a new location in Hyderabad.

Nithiya Ananthakrishnan, CEO of Algorics, said, "We are delighted to welcome DCDS to the Algorics team. Their strong reputation for clinical biometrics resourcing and their established team of experienced analytical professionals perfectly complement our capabilities. This acquisition represents an important milestone in Algorics' growth journey and will allow us to increase our scale, strengthen our offering for existing customers, and extend our market reach."

Vishnu Vardhan, Director of DCDS said, "Algorics has a well-deserved industry reputation for providing exceptional clinical data science solutions, and we are delighted to join them at this exciting point in their expansion. We look forward to continuing to enable our customers' success as part of the Algorics team."

The deal builds on 12 months of significant growth for Algorics in which it has brought on board an experienced leadership team, hired new talent, and added new clients to its portfolio.

About Algorics
Algorics is a data-focused biometrics service provider and provider of high-quality statistical solutions to leading pharmaceutical and clinical research organisations. We help our customers increase productivity and accelerate development with our technology-backed solutions to enable data standardisation and faster statistical reporting.

Learn more at

Categories: Biotechnology, Pharma, Corporate, Finance & Investor
Browse more news

Recent releases